BravoVax Attended 12th Enmore Bio Products Conference 2020

On August 6, 2020, the “12th Enmore Bio Products Conference 2020” opened in Haikou, capital city of Hainan Province, BravoVax CEO, Dr. Wu Ke, was invited to preside over the conference.

This conference, focusing on development of human vaccines, veterinary vaccines and blood products, was comprised of the three separate summits – “12th Human Vaccines Industry Summit 2020”, “8th Veterinary Vaccines Industry Summit 2020” and “8th Blood Products Industry Summit 2020”, with some 800 participants from nearly 50 institutions and companies attending.

Dr. Wu Ke presided over the opening ceremony and chaired the round-table – “R&D Strategy of COVID-19 Vaccines and Treatment for COVID-19”. Participates at the round-table discussion talked over issues and shared ideas on development progress of COVID-19 vaccines, expected scale of their industrialization and development strategy for emergency vaccines in future.

Senior experts from Jiangsu CDC, China National Biotec Group (CNBG), Minhai Bio, Innovax, Abogen Biosciences, etc attended the conference, exchanging their experiences and views on the latest clinical progress of human vaccines, leading technology and up-to-date R&D process of major human vaccines.